GL1X · GenesisL1 explorer

Research workbench

Xfel BETA2 ar structure by ligand exchange from alprenolol to carazolol.

Analyse Xfel BETA2 ar structure by ligand exchange from alprenolol to carazolol. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6PS0
Type
protein
Length
440 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P07550, D9IEF7
Ligands
CAU, CLR, OLA, SO4

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein440—P07550, D9IEF7

Ligands and binding sites

  • CAU · (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol · ligand · chains A
  • CLR · Cholesterol · ligand · chains A
  • OLA · Oleic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A
  • OLC · (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6PS0 · XFEL beta2 AR structure by ligand exchange from Alprenolol to Carazolol. · the same entry in another collection · chain A against A, TM-score 1.00
  • P07550 · AlphaFold monomer V2.0 prediction for beta-2 adrenergic receptor (P07550) · a predicted model of the same protein · chain A against A, TM-score 0.66

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.